Insights into Novel Drug Targets in Mycobacterium tuberculosis: Where Do We Stand and Where Do We Go from Here?

Dual pharmacological targeting of Mycobacterium tuberculosis (Mtb) PKNA/PKNB: A novel approach for the selective treatment of TB illness

Recent Developments of Some Natural Products Against My Cobacterium Tuberculosisinfection

SYNTHESIS OF PYRAZINAMIDE DERIVATIVES AS LEUCONOSTOC MESENTEROIDES GROWTH INHIBITOR AND OTHER MICROORGANISMS

Design, Synthesis and Antibacterial Study of New Agents Having 4-Thiazolidinone Pharmacophore

Isoniazid, Mechanism of action, Biological Activity, Resistance and Biotransformation

Geometrical and Topological Descriptors for Activities Modeling of some Potent Inhibitors against Mycobacterium Tuberculosis: A Genetic Functional Approach

Benzothiazinones PBTZ169 And BTZ0 43 Innovative Medicines For Re emergent Killer Tuberculosis

PIM KINASES INHIBITORS AND PYRIMIDINE-BASED ANTICANCER AGENTS

Review; Recent approaches on Tubulin Polymerization inhibitors (2018-2022)